Curanex Pharmaceuticals Inc

Stage 1 · Basing · week 3

As of Oct 22, 2026, Curanex Pharmaceuticals is in Stage 1, the basing phase, now in week 3 (since Oct 2, 2026). It closed at $5.20, 67.5% below its 52-week high and below its 200-day average, which is falling.

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. More about the company

$5.20

+2.97% today

$8.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is CURX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-08-26 → 2026-10-22

S? 41w

S4 16w

2025-08-262026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 41w → S4 16w → S1 3w current

Total tracked: 60 weeks across 3 stage runs.

CURX among Biotechnology379th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…379	CURXCuranex Pharmaceuticals Inc	Stage 1 · wk 3	21	+16.2%

vs 52W High

-67.5%

$3.66 lo$16.00 hi

67.5% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 3

1w13w26w

Week 3, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-16.7%

200 DMA: $6.24 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.19x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↑

Short-term trend rising strongly

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+16.2%

+38.3%

-41.3%

YTD

-29.3%

-55.5%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S1

Wk 3 · Vol 0.19x

2026-10-21S1

Wk 3 · Vol 0.15x

2026-10-20S1

Wk 3 · Vol 0.30x

2026-10-19S1

Wk 3 · Vol 0.27x

2026-10-16S1

Wk 3 · Vol 0.44x

2026-10-15S1

Wk 2 · Vol 0.66x

2026-10-14S1

Wk 2 · Vol 0.38x

2026-10-13S1

Wk 2 · Vol 0.00x

2026-10-12S1

Wk 2 · Vol 0.32x

2026-10-09S1

Wk 2 · Vol 0.64x

2026-10-08S1

Wk 1 · Vol 0.59x

2026-10-07S1

Wk 1 · Vol 4.58x

Moving averages & range

50 DMA

$4.71

200 DMA

$6.24

52W High

$16.00

52W Low

$3.66

5D Low

$4.62

Resistance levels (recent highs)

20d High

$5.31

60d High

$5.40

120d High

$7.50

250d High

$16.00

Next resistance

+2.1%

to 20d High

ROE

-411.1%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 1.5

Curanex Pharmaceuticals: quick answers

What stage is Curanex Pharmaceuticals in?

As of Oct 22, 2026, Curanex Pharmaceuticals (CURX) is in Stage 1, the basing phase. It entered Stage 1 on Oct 2, 2026 and is in week 3. What the four stages mean

Is Curanex Pharmaceuticals in an uptrend?

Not yet. Curanex Pharmaceuticals is in Stage 1, a base that can come before an uptrend. It trades 16.7% below its 200-day average, which is falling.

How far is Curanex Pharmaceuticals from its 52-week high?

Curanex Pharmaceuticals closed at $5.20 on Oct 22, 2026, 67.5% below its 52-week high of $16.00. Its 52-week low is $3.66.

How has Curanex Pharmaceuticals performed over the past year?

As of Oct 22, 2026, Curanex Pharmaceuticals is down 55.5% over the past year and down 29.3% so far in 2026.

Which sector and industry is Curanex Pharmaceuticals in?

Curanex Pharmaceuticals is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.